# TearClear

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tearclear

- Industry: Pharmaceuticals
- Headquarters: Newport Beach, US
- Website: www.tearclear.com
- Total disclosed funding: $27M
- Latest round: Series B (Aug 11, 2020)
- Investors on record: 3

## About

Founded in 2015 and based in Copley, US, TearClear Corp. is a company that develops preservative-free topical ophthalmic drugs. The drugs are designed to be chemical filters to remove the preservatives from multi-dose eye drop bottles before the drug is used into the eye.

## Funding rounds

- Series B, Aug 11, 2020, $22M — Bluestem Capital Company, Visionary Venture Fund, Flying L Partners
- Series A, May 30, 2017, $4.5M — Bluestem Capital Company, Visionary Venture Fund

## Investors

- Bluestem Capital Company (https://capitalatlas.ai/funds/bluestem-capital-company) — Series A, Series B
- Visionary Venture Fund (https://capitalatlas.ai/funds/visionary-venture-fund) — Series A, Series B
- Flying L Partners (https://capitalatlas.ai/funds/flying-l-partners) — Series B